Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus

Hyung Joon Joo; Sang A. Cho; Soon Jun Hong; Seung Ho Hur; Jang Ho Bae; Dong Ju Choi; Young Keun Ahn; Jong Seon Park; Rak Kyeong Choi; Donghoon Choi; Joon Hong Kim; Kyoo Rok Han; Hun Sik Park; So Yeon Choi; Jung Han Yoon; Hyeon Cheol Kwon; Seung Woon Rha; Kyung Kuk Hwang; Kyung Tae Jung; Seok Kyu Oh; Jae Hwan Lee; Eun Seok Shin; Kee Sik Kim; Hyo Soo Kim; Do Sun Lim

doi:10.1186/s12944-016-0374-5

Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus

Hyung Joon Joo, Sang A. Cho, Soon Jun Hong, Seung Ho Hur, Jang Ho Bae, Dong Ju Choi, Young Keun Ahn, Jong Seon Park, Rak Kyeong Choi, Donghoon Choi, Joon Hong Kim, Kyoo Rok Han, Hun Sik Park, So Yeon Choi, Jung Han Yoon, Hyeon Cheol Kwon, Seung Woon Rha, Kyung Kuk Hwang, Kyung Tae Jung, Seok Kyu OhJae Hwan Lee, Eun Seok Shin, Kee Sik Kim, Hyo Soo Kim, Do Sun Lim

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Background: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. Methods: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocardial InfarctiON Disease (DIAMOND) Korean multicenter registry were divided into two groups based on HDL-C level on admission: normal HDL-C group (HDL-C ≥ 40 mg/dL, n = 519) and low HDL-C group (HDL-C < 40 mg/dL, n = 465). The primary endpoint was 2-year major adverse cardiovascular events (MACE), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and target vessel revascularization (TVR). Results: The median follow-up duration was 730 days. The 2-year MACE rates were significantly higher in the low HDL-C group than in the normal HDL-C group (MACE, 7.44% vs. 3.49%, p = 0.006; cardiac death, 3.72% vs. 0.97%, p = 0.004; non-fatal MI, 1.75% vs. 1.55%, p = 0.806; TVR, 3.50% vs. 0.97%, p = 0.007). Kaplan-Meier analysis revealed that the low HDL-C group had a significantly higher incidence of MACE compared to the normal HDL-C group (log-rank p = 0.013). After adjusting for conventional risk factors, Cox proportional hazards analysis suggested that low HDL-C was an independent risk predictor for MACE (hazard ratio [HR] 3.075, 95% confidence interval [CI] 1.034-9.144, p = 0.043). Conclusions: In patients with diabetes mellitus, low HDL-C remained an independent risk predictor for MACE after adjusting for multiple risk factors during 2-year follow-up of AMI. Trial registration: This study was the sub-analysis of the prospective multi-center registry of DIAMOND (Diabetic acute myocardial infarction Disease) in Korea. This is the observational study supported by Bayer HealthCare, Korea. Study number is 15614. First patient first visit was 02 April 2010 and last patient last visit was 09 December 2013.

Original language	English
Pages (from-to)	1-8
Number of pages	8
Journal	Lipids in Health and Disease
Volume	15
Issue number	1
DOIs	https://doi.org/10.1186/s12944-016-0374-5
Publication status	Published - 2016 Nov 18

Bibliographical note

Publisher Copyright:
© 2016 The Author(s).

Keywords

Acute myocardial infarction
Diabetes mellitus
High-density lipoprotein cholesterol
Major adverse cardiovascular events

ASJC Scopus subject areas

Endocrinology, Diabetes and Metabolism
Endocrinology
Clinical Biochemistry
Biochemistry, medical

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s12944-016-0374-5

Cite this

Joo, H. J., Cho, S. A., Hong, S. J., Hur, S. H., Bae, J. H., Choi, D. J., Ahn, Y. K., Park, J. S., Choi, R. K., Choi, D., Kim, J. H., Han, K. R., Park, H. S., Choi, S. Y., Yoon, J. H., Kwon, H. C., Rha, S. W., Hwang, K. K., Jung, K. T., ... Lim, D. S. (2016). Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus. Lipids in Health and Disease, 15(1), 1-8. https://doi.org/10.1186/s12944-016-0374-5

Joo, HJ, Cho, SA, Hong, SJ, Hur, SH, Bae, JH, Choi, DJ, Ahn, YK, Park, JS, Choi, RK, Choi, D, Kim, JH, Han, KR, Park, HS, Choi, SY, Yoon, JH, Kwon, HC, Rha, SW, Hwang, KK, Jung, KT, Oh, SK, Lee, JH, Shin, ES, Kim, KS, Kim, HS & Lim, DS 2016, 'Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus', Lipids in Health and Disease, vol. 15, no. 1, pp. 1-8. https://doi.org/10.1186/s12944-016-0374-5

@article{3a60cc073a58417f9f0ad9f47be3ac5e,

title = "Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus",

abstract = "Background: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. Methods: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocardial InfarctiON Disease (DIAMOND) Korean multicenter registry were divided into two groups based on HDL-C level on admission: normal HDL-C group (HDL-C ≥ 40 mg/dL, n = 519) and low HDL-C group (HDL-C < 40 mg/dL, n = 465). The primary endpoint was 2-year major adverse cardiovascular events (MACE), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and target vessel revascularization (TVR). Results: The median follow-up duration was 730 days. The 2-year MACE rates were significantly higher in the low HDL-C group than in the normal HDL-C group (MACE, 7.44% vs. 3.49%, p = 0.006; cardiac death, 3.72% vs. 0.97%, p = 0.004; non-fatal MI, 1.75% vs. 1.55%, p = 0.806; TVR, 3.50% vs. 0.97%, p = 0.007). Kaplan-Meier analysis revealed that the low HDL-C group had a significantly higher incidence of MACE compared to the normal HDL-C group (log-rank p = 0.013). After adjusting for conventional risk factors, Cox proportional hazards analysis suggested that low HDL-C was an independent risk predictor for MACE (hazard ratio [HR] 3.075, 95% confidence interval [CI] 1.034-9.144, p = 0.043). Conclusions: In patients with diabetes mellitus, low HDL-C remained an independent risk predictor for MACE after adjusting for multiple risk factors during 2-year follow-up of AMI. Trial registration: This study was the sub-analysis of the prospective multi-center registry of DIAMOND (Diabetic acute myocardial infarction Disease) in Korea. This is the observational study supported by Bayer HealthCare, Korea. Study number is 15614. First patient first visit was 02 April 2010 and last patient last visit was 09 December 2013.",

keywords = "Acute myocardial infarction, Diabetes mellitus, High-density lipoprotein cholesterol, Major adverse cardiovascular events",

author = "Joo, {Hyung Joon} and Cho, {Sang A.} and Hong, {Soon Jun} and Hur, {Seung Ho} and Bae, {Jang Ho} and Choi, {Dong Ju} and Ahn, {Young Keun} and Park, {Jong Seon} and Choi, {Rak Kyeong} and Donghoon Choi and Kim, {Joon Hong} and Han, {Kyoo Rok} and Park, {Hun Sik} and Choi, {So Yeon} and Yoon, {Jung Han} and Kwon, {Hyeon Cheol} and Rha, {Seung Woon} and Hwang, {Kyung Kuk} and Jung, {Kyung Tae} and Oh, {Seok Kyu} and Lee, {Jae Hwan} and Shin, {Eun Seok} and Kim, {Kee Sik} and Kim, {Hyo Soo} and Lim, {Do Sun}",

note = "Publisher Copyright: {\textcopyright} 2016 The Author(s).",

year = "2016",

month = nov,

day = "18",

doi = "10.1186/s12944-016-0374-5",

language = "English",

volume = "15",

pages = "1--8",

journal = "Lipids in Health and Disease",

issn = "1476-511X",

publisher = "BioMed Central",

number = "1",

}

TY - JOUR

T1 - Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus

AU - Joo, Hyung Joon

AU - Cho, Sang A.

AU - Hong, Soon Jun

AU - Hur, Seung Ho

AU - Bae, Jang Ho

AU - Choi, Dong Ju

AU - Ahn, Young Keun

AU - Park, Jong Seon

AU - Choi, Rak Kyeong

AU - Choi, Donghoon

AU - Kim, Joon Hong

AU - Han, Kyoo Rok

AU - Park, Hun Sik

AU - Choi, So Yeon

AU - Yoon, Jung Han

AU - Kwon, Hyeon Cheol

AU - Rha, Seung Woon

AU - Hwang, Kyung Kuk

AU - Jung, Kyung Tae

AU - Oh, Seok Kyu

AU - Lee, Jae Hwan

AU - Shin, Eun Seok

AU - Kim, Kee Sik

AU - Kim, Hyo Soo

AU - Lim, Do Sun

PY - 2016/11/18

Y1 - 2016/11/18

N2 - Background: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. Methods: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocardial InfarctiON Disease (DIAMOND) Korean multicenter registry were divided into two groups based on HDL-C level on admission: normal HDL-C group (HDL-C ≥ 40 mg/dL, n = 519) and low HDL-C group (HDL-C < 40 mg/dL, n = 465). The primary endpoint was 2-year major adverse cardiovascular events (MACE), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and target vessel revascularization (TVR). Results: The median follow-up duration was 730 days. The 2-year MACE rates were significantly higher in the low HDL-C group than in the normal HDL-C group (MACE, 7.44% vs. 3.49%, p = 0.006; cardiac death, 3.72% vs. 0.97%, p = 0.004; non-fatal MI, 1.75% vs. 1.55%, p = 0.806; TVR, 3.50% vs. 0.97%, p = 0.007). Kaplan-Meier analysis revealed that the low HDL-C group had a significantly higher incidence of MACE compared to the normal HDL-C group (log-rank p = 0.013). After adjusting for conventional risk factors, Cox proportional hazards analysis suggested that low HDL-C was an independent risk predictor for MACE (hazard ratio [HR] 3.075, 95% confidence interval [CI] 1.034-9.144, p = 0.043). Conclusions: In patients with diabetes mellitus, low HDL-C remained an independent risk predictor for MACE after adjusting for multiple risk factors during 2-year follow-up of AMI. Trial registration: This study was the sub-analysis of the prospective multi-center registry of DIAMOND (Diabetic acute myocardial infarction Disease) in Korea. This is the observational study supported by Bayer HealthCare, Korea. Study number is 15614. First patient first visit was 02 April 2010 and last patient last visit was 09 December 2013.

AB - Background: It is still unclear whether low high-density lipoprotein cholesterol (HDL-C) affects cardiovascular outcomes after acute myocardial infarction (AMI), especially in patients with diabetes mellitus. Methods: A total of 984 AMI patients with diabetes mellitus from the DIabetic Acute Myocardial InfarctiON Disease (DIAMOND) Korean multicenter registry were divided into two groups based on HDL-C level on admission: normal HDL-C group (HDL-C ≥ 40 mg/dL, n = 519) and low HDL-C group (HDL-C < 40 mg/dL, n = 465). The primary endpoint was 2-year major adverse cardiovascular events (MACE), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), and target vessel revascularization (TVR). Results: The median follow-up duration was 730 days. The 2-year MACE rates were significantly higher in the low HDL-C group than in the normal HDL-C group (MACE, 7.44% vs. 3.49%, p = 0.006; cardiac death, 3.72% vs. 0.97%, p = 0.004; non-fatal MI, 1.75% vs. 1.55%, p = 0.806; TVR, 3.50% vs. 0.97%, p = 0.007). Kaplan-Meier analysis revealed that the low HDL-C group had a significantly higher incidence of MACE compared to the normal HDL-C group (log-rank p = 0.013). After adjusting for conventional risk factors, Cox proportional hazards analysis suggested that low HDL-C was an independent risk predictor for MACE (hazard ratio [HR] 3.075, 95% confidence interval [CI] 1.034-9.144, p = 0.043). Conclusions: In patients with diabetes mellitus, low HDL-C remained an independent risk predictor for MACE after adjusting for multiple risk factors during 2-year follow-up of AMI. Trial registration: This study was the sub-analysis of the prospective multi-center registry of DIAMOND (Diabetic acute myocardial infarction Disease) in Korea. This is the observational study supported by Bayer HealthCare, Korea. Study number is 15614. First patient first visit was 02 April 2010 and last patient last visit was 09 December 2013.

KW - Acute myocardial infarction

KW - Diabetes mellitus

KW - High-density lipoprotein cholesterol

KW - Major adverse cardiovascular events

UR - http://www.scopus.com/inward/record.url?scp=85016924197&partnerID=8YFLogxK

U2 - 10.1186/s12944-016-0374-5

DO - 10.1186/s12944-016-0374-5

M3 - Article

C2 - 27863493

AN - SCOPUS:85016924197

SN - 1476-511X

VL - 15

SP - 1

EP - 8

JO - Lipids in Health and Disease

JF - Lipids in Health and Disease

IS - 1

ER -

Impact of low high-density lipoprotein-cholesterol level on 2-year clinical outcomes after acute myocardial infarction in patients with diabetes mellitus

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this